Bio-Rad Laboratories

$597.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$12.80 (+2.19%) Today

$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell BIO and other stocks, options, and ETFs commission-free!

About BIO

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA. The listed name for BIO is Bio-Rad Laboratories, Inc.Class A.

CEO

Norman D. Schwartz

Employees

8,000

Headquarters

Hercules, California

Founded

1952

Market Cap

18.17B

Price-Earnings Ratio

4.63

Dividend Yield

—

Average Volume

302.36K

High Today

$602.28

Low Today

$590.69

Open Price

$593.84

Volume

157.36K

52 Week High

$689.00

52 Week Low

$309.38

BIO Earnings

$0.00

$1.34

$2.67

$4.01

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours